News | March 23, 2024
Sharon Bio-Medicine resumes operations
Operations of Line II was stopped due to a fire incident earlier
Operations of Line II was stopped due to a fire incident earlier
The MDC business produces components for medical device manufacturers globally with a focus on precious metal alloys and nitinol
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
The Cabinet has approved budgetary support of Rs. 2207.50 crore in the 15th Finance Commission Cycle to run CAPFIMS as a campus of AIIMS, New Delhi.
These approvals mark significant progress for Venus Remedies in expanding its market presence
The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
Subscribe To Our Newsletter & Stay Updated
